MetaTOC stay on top of your field, easily

Safety of intravenous neridronate in pediatric patients: insights from the monocentric retrospective NAPOLEON cohort

, , , , , , , , , , ,

Therapeutic Advances in Musculoskeletal Disease

Published online on

Abstract

Therapeutic Advances in Musculoskeletal Disease, Volume 18, January-December 2026.
Background:Evidence on the safety of intravenous neridronate (IV NER) in children with conditions other than osteogenesis imperfecta (OI) remains limited. This retrospective study describes adverse events, including acute phase reactions (APR) and ...